Acquisition of Pharmaco Everolimus 0.5 Mg for Hsj Tender - 144659870

Procurement Summary

Country: Chile

Summary: Acquisition of Pharmaco Everolimus 0.5 Mg for Hsj

Deadline: 31 Jul 2026

Posting Date: 07 Jul 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 144659870

Document Ref. No.: 1549-57-LP26

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: CLP 210000000

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Products or services: Sirolimus 1º That the Ministry of Health is responsible for exercising the function that corresponds to the State of guaranteeing free and equal access to actions for the promotion, protection and recovery of health and rehabilitation of the sick person; as well as coordinate, control and, when appropriate, execute such actions. For its part, the San José Hospital is a Network Self-Management Establishment, functionally deconcentrated, whose mission is to carry out the health actions that have been entrusted to him. 2. That, in accordance with the provisions of Exempt Resolution NO 443, dated January 26, 2026, which approves the Annual Purchasing and Contracting Plan for the year 2026 for the San José Hospital Complex, the acquisition of drugs of code 214-4380 Everolimus 0.5 MG. 3. That the required drug is not found in the Catalog of the Framework Agreement, provided in the State Purchasing and Contracting Information and Management System, according to a certificate issued by the Procurement Headquarters of the San José Hospital, dated May 13, 2026, in accordance with the provisions of article 35 bis, second paragraph, of Law NO19, 886 and article 29 of the regulations of the purchasing law. 4. That, in the case of goods that, Due to their nature, they cannot be reused or shared. In accordance with the provisions of article 28, second paragraph, of the regulations of the purchasing law, the San José Hospital is exempt from the consultation procedure with the economic platform. circular. 5. That the required drug is not intermediated, because the supplier awarded in the CENABAST tender does not offer with measurement of Plasma Levels, required by the Hospital and in addition they are awarded to different suppliers each. one of the presentations and allocation to a single provider is required to ensure the stability of plasma levels in those patients who require more than one presentation...

Documents

 Tender Notice